Literature DB >> 16810122

CD4(+) T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy.

Salvador Resino1, Elena Seoane, Maria Dolores Gurbindo Gutiérrez, Juan Antonio León, Maria Angeles Muñoz-Fernández.   

Abstract

OBJECTIVE: The aim of this study was to analyze the association between CD4(+) depletion and immune activation in HIV-1-infected children on highly active antiretroviral therapy (HAART). DESIGN AND
SETTING: We carried out a cross-sectional study to determine the profile of several immunologic parameters in 143 children on HAART for more than 24 weeks. Children were stratified according to current immunologic status (CD4 < or =15%, 15%-25%, and > or =25%) and viral load (VL) levels (<400 copies/mL; 400-10,000 copies/mL; and >10,000 copies/mL). We also studied 23 uninfected children as healthy controls.
METHODS: Viral load (HIV-RNA copies per milliliter) was quantified using reverse transcriptase polymerase chain reaction molecular assay. T-cell subsets were determined by multiparametric flow cytometry.
RESULTS: HIV-infected children with low percentage of CD4(+) had high memory (CD45RO(+)) and low naive (CD45RA(+)) CD4(+) and CD8(+) T-cell values. Furthermore, children with CD4(+) >25% had similar memory and naive CD4(+) values as the healthy control group, whereas memory and naive CD8(+) subsets were different from the healthy control values. In these HIV-infected children, when CD4(+) was depleted, the amount of naive plus central memory CD8(+) (CD28(+)CD57(-)) cells was decreased, whereas effector CD8(+) (CD28(-)CD57(+)) cells were upregulated, and these values were always higher than healthy control values. Furthermore, children with low percentage of CD4(+) showed significant upregulation of HLA-DR(+)CD38(+) and HLA-DR(+) in both CD4(+) and CD8(+) T-cells independent of VL levels.
CONCLUSIONS: Our data suggest that elevated immune activation could be responsible for CD4(+) depletion rather than HIV replication because immunologic status is associated directly to immune activation and not to VL levels in HIV-infected children on HAART.

Entities:  

Mesh:

Year:  2006        PMID: 16810122     DOI: 10.1097/01.qai.0000222287.90201.d7

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  12 in total

1.  Immunologic risk factors for early mortality after starting antiretroviral therapy in HIV-infected Zambian children.

Authors:  Kaitlin Rainwater-Lovett; Hope C Nkamba; Mwangelwa Mubiana-Mbewe; Carolyn Bolton Moore; William J Moss
Journal:  AIDS Res Hum Retroviruses       Date:  2012-10-31       Impact factor: 2.205

2.  Short-term risk of HIV disease progression and death in Ugandan children not eligible for antiretroviral therapy.

Authors:  Edwin D Charlebois; Theodore D Ruel; Anne F Gasasira; Jane Achan; Frederick Kateera; Caroline Akello; Huyen Cao; Grant Dorsey; Philip J Rosenthal; Isaac Ssewanyana; Moses R Kamya; Diane V Havlir
Journal:  J Acquir Immune Defic Syndr       Date:  2010-11       Impact factor: 3.731

3.  Characteristics of lymphocyte subsets in HIV-infected, long-term nonprogressor, and healthy Asian children through 12 years of age.

Authors:  Jintanat Ananworanich; Tanakorn Apornpong; Pope Kosalaraksa; Tanyathip Jaimulwong; Rawiwan Hansudewechakul; Chitsanu Pancharoen; Torsak Bunupuradah; Mom Chandara; Thanyawee Puthanakit; Chaiwat Ngampiyasakul; Jurai Wongsawat; Suparat Kanjanavanit; Wicharn Luesomboon; Phennapha Klangsinsirikul; Nicole Ngo-Giang-Huong; Stephen J Kerr; Sasiwimol Ubolyam; Tawan Mengthaisong; Rebecca S Gelman; Kovit Pattanapanyasat; Vonthanak Saphonn; Kiat Ruxrungtham; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2010-12       Impact factor: 10.793

4.  The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda.

Authors:  Isaac Ssewanyana; Chris A R Baker; Theodore Ruel; Stephanie Bousheri; Moses Kamya; Grant Dorsey; Philip J Rosenthal; Edwin Charlebois; Diane Havlir; Huyen Cao
Journal:  AIDS Res Hum Retroviruses       Date:  2009-01       Impact factor: 2.205

5.  Immune reconstitution in human immunodeficiency virus type 1-infected children with different virological responses to anti-retroviral therapy.

Authors:  A Anselmi; D Vendrame; O Rampon; C Giaquinto; M Zanchetta; A De Rossi
Journal:  Clin Exp Immunol       Date:  2007-10-22       Impact factor: 4.330

Review 6.  Role of HIV Gp41 mediated fusion/hemifusion in bystander apoptosis.

Authors:  H Garg; R Blumenthal
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

Review 7.  Immune activation and paediatric HIV-1 disease outcome.

Authors:  Julia M Roider; Maximilian Muenchhoff; Philip J R Goulder
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

8.  Dynamics of T cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan children.

Authors:  Theodore Ruel; Isaac Ssewanyana; Jane Achan; Anne Gasasira; Moses R Kamya; Adeodata Kekitiinwa; Joseph K Wong; Huyen Cao; Diane Havlir; Edwin D Charlebois
Journal:  Clin Immunol       Date:  2009-03-19       Impact factor: 3.969

9.  The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination.

Authors:  Christine E Jones; Anneke C Hesseling; Nontobeko G Tena-Coki; Thomas J Scriba; Novel N Chegou; Martin Kidd; Robert J Wilkinson; Beate Kampmann
Journal:  AIDS       Date:  2015-01-14       Impact factor: 4.177

Review 10.  HIV-1 induced bystander apoptosis.

Authors:  Himanshu Garg; Jonathon Mohl; Anjali Joshi
Journal:  Viruses       Date:  2012-11-09       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.